AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Maphoshane Nchabeleng

Maphoshane Nchabeleng

Sefako Makgatho Health Sciences University - Pretoria / South Africa
Others
AD Scientific Index ID: 4992906
Sefako Makgatho Gesondheidswetenskappe Universiteit
person_outline Maphoshane Nchabeleng's MOST POPULAR ARTICLES
1-) Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study The Lancet infectious diseases 11 (7), 507-515, 2011
2-) Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses The Lancet 399 (10339), 1941-1953, 2022
3-) Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120–MF59 in adults New England Journal of Medicine 384 (12), 1089-1100, 2021
4-) Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study The Lancet Infectious Diseases 18 (12), 1350-1359, 2018
5-) Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study The Lancet infectious diseases 14 (5), 388-396, 2014